Progression to Critical Illness and Death in Patients With Breakthrough Hospitalizations

Autor: Geehan Suleyman, Raef Fadel, Ayman Alsaadi, Luis Ng Sueng, Ali Ghandour, Ahmad Alkhatib, Tarandeep Singh, Austin Parsons, Joseph Miller, Mayur Ramesh, Indira Brar, George Alangaden
Rok vydání: 2022
Předmět:
Zdroj: Open Forum Infectious Diseases. 9
ISSN: 2328-8957
DOI: 10.1093/ofid/ofac213
Popis: Background Characterization of disease progression and outcomes after coronavirus disease 2019 (COVID-19)–related hospitalization in vaccinated compared with unvaccinated individuals is limited. Methods This was a retrospective case–control study of symptomatic vaccinated (cases) and unvaccinated (controls) participants hospitalized for COVID-19 between December 30, 2020, and September 30, 2021, in Southeast Michigan. Hospitalized adult patients with lab-confirmed COVID-19 were identified through daily census report. Breakthrough infection was defined as detection of severe acute respiratory syndrome coronavirus 2 ≥14 days after completion of the primary vaccination series. The association between prior vaccination and critical COVID-19 illness (composite of intensive care unit [ICU] admission, invasive mechanical ventilation [IMV], 28-day mortality) was examined. Results Two hundred ten (39%) fully vaccinated and 325 (61%) unvaccinated patients were evaluated. Compared with controls, cases were older, had more comorbidities (4 [3–7] vs 2 [1–4]; P Conclusions COVID-19-vaccinated patients were less likely to develop critical COVID-19 illness and more likely to survive. Disease severity at presentation was a predictor of adverse outcomes regardless of vaccination status.
Databáze: OpenAIRE